Rare Disease Firm Audentes Closes $30M Series A Financing
By Catherine Shaffer
Thursday, July 18, 2013
Audentes Inc., of San Francisco, closed a Series A financing round worth $30 million. OrbiMed Advisors led the round with participation by 5AM Ventures and Versant Ventures.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.